ライフサイエンス出版株式会社

FacebookTwitterInstagram
menu

Japanese Pharmacology & Therapeutics(JPT)

Vol. 26 Suppl. 1 1998

*All papers include English abstract

■Toxicological Studies ofMaxacalcitol (22-0xacalcitriol : OCT), a Novel 1α, 25-Dihydroxyvitamin D3 (Calcitriol)Derivative, for theTreatment of Hyperparathyroidism and Psoriasis

Single-dose intravenous toxicity study of OCT in rats

K. Watanabe, et al.

Jpn Pharmacol Ther 1998 26(Suppl.1) s5-9*


Single-dose intravenous toxicity study of OCT in dogs

K. Watanabe, et al.

Jpn Pharmacol Ther 1998 26(Suppl.1) s11-20*


Three-month intravenous toxicity study of OCT in rats

K. Watanabe, et al.

Jpn Pharmacol Ther 1998 26(Suppl.1) s21-43*


Three-month intravenous toxicity study of OCT in dogs

Y. Misawa, et al.

Jpn Pharmacol Ther 1998 26(Suppl.1) s45-79*


Twelve-month intravenous toxicity study of OCT in rats

K. Watanabe, et al.

Jpn Pharmacol Ther 1998 26(Suppl.1) s81-118*


Twelve-month intravenous toxicity study of OCT in dogs

Y. Misawa, et al.

Jpn Pharmacol Ther 1998 26(Suppl.1) s119-73*


Fertility study of OCT in rats by intravenous administration

H. Hara, et al.

Jpn Pharmacol Ther 1998 26(Suppl.1) s175-86*


Teratological study of OCT in rats by intravenous administration

H. Hara, et al.

Jpn Pharmacol Ther 1998 26(Suppl.1) s187-200*


Teratological study of OCT in rabbits by intravenous administration

H. Hara, et al.

Jpn Pharmacol Ther 1998 26(Suppl.1) s201-8*


Peri-and post-natal study of OCT in rats by intravenous administration

K. Mizoguchi, et al.

Jpn Pharmacol Ther 1998 26(Suppl.1) s209-24*


Antigenicity study of OCT in guinea pigs and mice

K. Marutani, et al.

Jpn Pharmacol Ther 1998 26(Suppl.1) s225-30*


Genotoxicity studies of OCT

M. Inoue, et al.

Jpn Pharmacol Ther 1998 26(Suppl.1) s231-7*


General pharmacology of OCT

M. Kurata, et al.

Jpn Pharmacol Ther 1998 26(Suppl.1) s239-54*